Article
Comparative immunogenicity and structural analysis of epitopes of different bacterial L-asparaginases
11 Feb 2016
Abstract excerpt
BACKGROUND: E.coli type II L-asparaginase is widely used for treatment of acute lymphoblastic leukemia. However, serious side effects such as allergic or hypersensitivity reactions are common for L-asparaginase treatment. Methods for minimizing immune response on L-asparaginase treatment in human include bioengeneering of less immunogenic version of the enzyme or utilizing the homologous enzymes of different...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
